-+ 0.00%
-+ 0.00%
-+ 0.00%

NUVECTIS PHARMA - CIPROCOPAN (NXP100) RECEIVES MARKETING APPROVAL IN CHINA FOR TREATMENT-NAIVE PNH PATIENTS

Reuters·07/23/2026 11:30:00

Please log in to view news